| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192779 | Annals of Allergy, Asthma & Immunology | 2009 | 7 Pages |
Abstract
Although the AMP-induced decline in FVC in asthmatic patients is similar to that observed with equipotent concentrations of methacholine, the apparently different effect of ICSs on changes in FVC induced by each agonist suggests that the information provided by the 2 bronchoconstrictor agents is not interchangeable and that the information generated by the analysis of the effect of each agonist on FEV1 and FVC may be complementary.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Luis PhD, Victoria MD, Pablo MD, Desiree MD, Julio PhD,